Objectives: Coexisting aortic root and mitral valve pathology is increasingly recognized among patients undergoing surgery. We characterized the pathology and surgical outcomes of patients with combined aortic root and mitral disease.
ABSTRACT
Objectives: Coexisting aortic root and mitral valve pathology is increasingly recognized among patients undergoing surgery. We characterized the pathology and surgical outcomes of patients with combined aortic root and mitral disease.
Methods: From 1987 to 2016, 118 patients (age 52.40 AE 17.71 years) underwent concomitant aortic root and mitral procedures (excluding aortic stenosis, endocarditis, and reoperations). Aortic root pathologies included degenerative aneurysm (94%) and aortic dissection (6%). The aortic valve was bicuspid in 15% of patients and had normally functioning tricuspid leaflets in 23% of patients. Marfan syndrome was present in 34 patients (29%). Degenerative mitral disease predominated (78%). Mitral procedures were repair (86%) and replacement (14%), and root procedures were valve-preserving root reimplantation (36%), Bentall procedure (47%), and homograft root replacement (17%). In the last 10 years, the combination of valve-preserving root reimplantation and mitral repair has increased to 50%. Kaplan-Meier and competing risk analyses were used to estimate survival and reoperation.
Results: There were 2 (1.7%) operative deaths with survival of 79% and 71% at 10 and 15 years, respectively, and reoperation rates of 4.7% and 12% after 5 and 10 years, respectively. There were no operative deaths in patients with combined valve-preserving root reimplantation and mitral repair, with survival of 89% and reoperation rate of 7.8% at 10 years. Among patients with Bentall/homograft and mitral operation, survival was 73% and reoperation was 9.8% at 10 years.
Conclusions:
In patients with aortic root and mitral pathology, combined surgical risk is low and valve durability is high. When possible, valve-preserving root reimplantation and mitral repair should be considered to avoid prosthesis degeneration, anticoagulation, and lifestyle limitations. (J Thorac Cardiovasc Surg 2017;153: Trends in operative strategy in patients undergoing combined operations.
Central Message
When possible, VPRR and MV repair should be considered in aortic root and MV pathology.
Perspective
Surgeons increasingly are encountering patients with coexisting aortic root and MV pathology. Combined aortic root and MV surgery is safe and associated with excellent long-term survival and durability. When possible, preserving both valves should be used to avoid prosthesis degeneration, anticoagulation, and lifestyle limitations.
See Editorial Commentary page 1031.
See Editorial page 1021.
Recent studies demonstrate that a small but important minority of patients presenting with aortic root pathology have concomitant mitral valve (MV) dysfunction (7%), and recognition of this association is increasingly common. [1] [2] [3] This combination of pathologies is particularly common in patients with connective tissue disorders, such as Marfan syndrome and Loeys-Dietz syndrome.
2,4-6 In addition, patients presenting with MV pathology occasionally have concomitant aortic root dilatation that is incidentally discovered during their preoperative workup, which often includes computed tomography (CT). Aortic valve-preserving root reimplantation (VPRR), replacement of the aortic root with valved conduits or allografts, and MV repair or replacement are established surgical options to treat these common valve and aortic root pathologies. However, the combination of an MV operation with an aortic root procedure is more demanding than either operation alone, 7 and knowledge regarding clinical outcomes is limited. 1, 3, [8] [9] [10] [11] This study sought to characterize the pathology, surgical outcomes, long-term survival, and valve durability of patients undergoing combined primary aortic root and MV operations.
MATERIALS AND METHODS Patients
A total of 360 adult patients underwent primary combined aortic root and MV surgery between January 1987 and January 2016 at the Cleveland Clinic. Patients with aortic stenosis, endocarditis, rheumatic MV disease, and reoperations were excluded to focus on patients who might be candidates for combined repair. A total of 118 patients met the inclusion criteria. Use of these data for research was approved by the Cleveland Clinic Institutional Review Board, with patient consent waived. Preoperative patient characteristics are summarized in Table 1 .
Echocardiography
All patients underwent a comprehensive echocardiogram, using commercially available instruments as part of standard clinical diagnostic evaluation. Cardiac measurements were obtained according to recommendations, 12, 13 and left ventricular ejection fraction was calculated using Simpson's biplane method. Diastolic function was graded using standard techniques.
14 Diagnosis of bicuspid aortic valve was based on multiple views made during systole, demonstrating 2 aortic valve cusps; a raphe was noted when present. 13 Annuloaortic ectasia was identified when the diameter of the aortic annulus was increased out of proportion to the size of the aortic leaflets. 15 A semiquantitative scale of 0 to 4 (trace, mild, moderate, moderate to severe, and severe) was used to stratify valvular regurgitation on the basis of spectral and color Doppler, left atrial size, and width of the regurgitant jet. 16 
Cross-Sectional Imaging Measurements
Preoperative cross-sectional imaging was available in 68 patients (58%). Detailed imaging analyses were made from CT and magnetic resonance imaging using 3-dimensional reconstruction software (TeraRecon, Foster City, Calif). Aortic cross-sectional diameters were collected in the orthonormal plane to the centerline of the aorta at 4 different landmarks based on the American College of Cardiology/American Heart Association consensus guidelines 17 and the technique of Mendoza and colleagues. 18 
Surgical Details
The decision to perform combined MV and aortic root procedures was made by the cardiologist and cardiothoracic surgeon at the time of original clinical evaluation. In adhering to the guidelines, 17, 19 we offer early prophylactic aortic replacement at an ascending or sinus diameter 5.0 cm or greater, cross-sectional area to height ratio greater than 10 cm 2 /m, or the rate of increase in aortic dilation is 0.5 cm or greater per year in patients with bicuspid aortic valve aortopathy. If patients with bicuspid valves and associated aortic root enlargement have indications for aortic valve replacement because of severe aortic stenosis or aortic regurgitation, it is recommended that repair of the aortic root or replacement of the ascending aorta be performed if the diameter of these structures is greater than 4.5 cm. Surgery is indicated at lower size thresholds in patients with certain genetic syndromes, including a threshold of 4.5 to 5.0 cm for Marfan syndrome and 4.2 cm for Loeys-Dietz syndrome or a confirmed TGFBR1 or TGFBR2 mutation. In the absence of a bicuspid valve or genetic/familial cause of aortic enlargement, the threshold recommended for elective surgery at our center is an aortic diameter of 5.5 cm for patients with degenerative thoracic aneurysms, chronic aortic dissections, penetrating atherosclerotic ulcers, mycotic aneurysms, or pseudoaneurysms.
Posterior MV leaflet repair was achieved by triangular/quadrangular resection, folding valvuloplasty, and sliding repair. Anterior MV leaflet repair was achieved by chordal transfer or insertion of polytetrafluoroethylene neochordae. MV repair was achieved in 102 patients (86%) and included a combination of annuloplasty and chordal/leaflet procedures in 63 patients (62%), annuloplasty alone in 34 patients (33%), and chordal/leaflet procedures alone in 5 patients (5%). Six patients (5%) underwent bioprosthetic MV replacement, and 10 patients (9%) underwent mechanical MV replacement. The aortic root operative techniques have been described, including a modified valve reimplantation by Svensson and colleagues, 1, 20 composite mechanical valve implantation, 21, 22 standard techniques for biologic implants with coronary buttons, and allograft root implantation by the inclusion or button technique. Homograft root replacement was more common earlier in the series. At that time, there was a general belief (since disproved) that homografts had greater durability than other bioprostheses. 23 Today, we are less likely to use a homograft in a patient who does not have endocarditis. Aortic root/valve procedures included valve-preserving reimplantation in 43 patients (36%), Bentall procedure in 55 patients (bio-Bentall 29, mechanical-Bentall 26; 47%), and homograft in 20 patients (17%) ( Table 2) .
Forty-three patients (36%) received concomitant extended ascending aorta replacement, 19 patients (16%) underwent coronary artery bypass graft surgery, 5 patients (4%) underwent patent foramen ovale/atrial septal defect closure, 14 patients (12%) received an ablation for atrial fibrillation, and 12 patients (10%) underwent tricuspid valve repair. A video demonstrating one of these combined mitral valve repair and valve-preserving aortic root reimplantation procedures is included with this article (Video 1).
End Points
The primary end point was time-related mortality from the date of operation to death or last follow-up. Secondary end points included in-hospital mortality, and complications as defined by the Society of Thoracic Surgeons
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Acquired: Aortic Symposium: Aortic RootNational Cardiac Database (http://www.sts.org/sites/default/files/documents/ STSAdultCVDataSpecificationsV2_81.pdf), as well as time-related reoperation for MV or aortic root or valve disease. Patients were actively followed up at 2-year intervals after surgery by mailed institutional review board-approved questionnaire, telephone interview, or examination at Cleveland Clinic. The mortality follow-up information was supplemented by query of the Social Security Death Master File on October 27, 2011.
Data Analysis
Categoric variables are summarized as percentages, and continuous variables are presented as mean AE standard deviation. All measurements were performed by 1 observer, and intraobserver variability was determined by comparing measurements at individual landmarks taken by the same blinded observer in 10 randomly selected patients. Bland-Altman analysis was computed to assess measurement reproducibility. Time-to-event Kaplan-Meier analysis was performed for survival.
Competing Risk Analysis for Reoperation. Common interval was taken as the earliest of the outcome (death and any valve/root reoperation) or the interval between surgery and the end of follow-up for those patients still alive and having not experienced a reoperation. Time zero is time of surgery. Freedom from each event is estimated by the nonparametric product limit method of Andersen and colleagues. 24 Competing risk analyses were performed for the entire population, combined VPRR and MV repair group, and combined MV replacement and Bentall/Homograft procedure group.
All analyses were performed using SPSS (version 15.0.0; SPSS Inc, Chicago, Ill), MATLAB software (V7.8, R2009A, Natick, Mass), and SAS statistical software (SAS version 9.2; SAS Institute, Cary, NC).
RESULTS

Patient Characteristics
The most common preoperative presentations included degenerative MV disease (n ¼ 92, 78%) and degenerative aortic root aneurysm (n ¼ 111, 94%). Mean age of patients at operation was 52 AE 17.7 years, and 96 (81%) were male. At the time of presentation, all patients had mitral regurgitation (MR) 2þ or greater, and 102 patients (86%) had aortic regurgitation. Twenty-seven patients (23%) had a normally functioning tricuspid aortic valve, 18 patients (15%) had bicuspid aortic valve disease, 29 patients (25%) had Marfan syndrome, and 5 patients (4%) had combined bicuspid aortic valve and Marfan syndrome. Substantial percentages of patients had severe aortic regurgitation (n ¼ 36, 31%) and severe MR (n ¼ 59, 50%).
The most common MV pathology was bileaflet prolapse, present in 50 patients (43%). The most common MV procedures were mitral annuloplasty in 97 patients (82%) and posterior leaflet resection in 45 patients (38%). Although the most common type of aortic root surgery was a Bentall procedure (n ¼ 55, 47%), the combination of valve-preserving reimplantation for the aortic root/ valve and MV repair has increased in recent experience (Figure 1 ).
During the cross-sectional imaging analysis, the intraobserver variability was 3 mm at the aortic sinus, 5 mm at the sinotubular junction, and 6 mm at the ascending aorta ( Figure E1 ). The mean maximum aortic diameter was 46.6 AE 10 mm and was most commonly at the level of the sinuses of Valsalva (Table 1) . 
Survival
Median follow-up time among survivors was 5.31 years (interquartile range, 1-12 years), with 20% followed for more than 13 years and 10% followed for more than 16 years. There was an 86% response rate to the 2-year follow-up questionnaire and a mean rate to all questionnaires of 70%, but only 1 patient was completely lost to follow-up.
Time-related survival of the patients after 1, 5, 10, and 15 years was 98%, 91%, 79%, and 71%, respectively. In patients who underwent combined VPRR and MV repair (n ¼ 41, 35%), time-related survival after 1, 5, and 10 years was 97%, 97%, and 89%, respectively. Among patients with combined Bentall/homograft root replacement and MV surgery (n ¼ 75, 64%), timerelated survival after 1, 5, and 10 years was 97%, 88%, and 73%, respectively. Figure 2 demonstrates the timerelated survival of patients who underwent combined MV and aortic root procedures.
Competing Risk Analysis for Reoperation
Median active follow-up time for valve/root reoperation was 5 years (interquartile range, 0.57-11 years). Twenty percent of the patients were followed for more than 12 years, and 10% of the patients were followed for more than 14 years. From surgery to 2 years, the risk of reoperation exceeded the risk of death. In the later stages of follow-up, the risk of death exceeds the risk of reoperation. At 1, 2, 5, and 10 years, the risk of reoperation was 4.7%, 4.7%,4.7%, and 12% versus 2.6%, 3.8%, 7.7%, and 22% for death, respectively (Figure 3, A) .
The modes of valvular failure were recurrent severe MR after MV repair (n ¼ 4), endocarditis after mechanical valve replacement (n ¼ 1), degenerated aortic homograft (n ¼ 4), valve dysfunction after valve-preserving aortic root replacement (n ¼ 3), and structural valve deterioration after Bentall procedure (n ¼ 2). Combined valve-preserving aortic root reimplantation and mitral valve repair. Before the first decade of follow-up, the risk of reoperation was greater than the risk of death. At 1, 2, 5, and 10 years, the risk of reoperation was 7.8%, 7.8%, 7.8%, and 7.8% versus 2.8%, 2.8%, 2.8%, and 21% for risk of death, respectively (Figure 3, B) . Bentall/homograft root replacement and mitral valve surgery. From surgery to end of follow-up, the risk of death was greater than the risk of reoperation. At 1, 2, 5, and 10 years, the risk of reoperation was 3.0%, 3.0%, 3.0%, and 9.8% versus 3.0%, 4.4%, 9.8%, and 24% for risk of death, respectively (Figure 3, C) .
DISCUSSION
Key Findings
The coexistence of aortic root and MV pathology is increasingly recognized among surgical patients. Patients undergoing primary combined aortic root and MV surgery are young. The most common pathologies are root aneurysm without dissection and degenerative MV disease. Combined aortic root and MVoperations are safe in centers with expertise in both procedures and are associated with excellent long-term survival and durability. Our recent experience confirms that preservation of both valves provides excellent outcomes and durability through the first decade.
Surgical Approaches and Outcomes
The benefits of MV repair versus replacement for patients with degenerative MV disease are well documented. [25] [26] [27] Likewise, valve-preserving aortic root reimplantation is preferred for patients with aortic root aneurysm and a salvageable aortic valve. 28 Advantages include low surgical risk, potential for late durability, improved postoperative ventricular remodeling, avoidance of anticoagulation and its related complications, and no need for lifestyle limitations. In our relatively large cohort, operative mortality of 1.7% was lower than in other smaller series and is similar to that for the general population of patients undergoing isolated MV or aortic root operation. 1, 2, [29] [30] [31] We recommend that combined preservation of both valves for degenerative disease, when possible, is preferred as long as the safety is not compromised, as is often the case in experienced centers. In our center, this frequently involves the collaboration of 2 surgeons, 1 with special expertise in the management of aortic root pathology and 1 with extensive experience in MV repair.
The performance of valve-preserving aortic root replacement in the setting of aortic dissection is controversial. The safe use of valve-preserving aortic root replacement has been described for selected patients with acute ascending aortic dissection. [32] [33] [34] As we have gained experience and comfort performing this operation in our institution, we have applied it to selected younger patients but have not yet combined it with mitral repair for this indication. In the current series, 7 patients (6%) had aortic root dissection with moderate to severe aortic regurgitation and mitral disease. They underwent MV repair and bioBentall root replacement. They tended to be aged more than 70 years and had some evidence of degeneration of the aortic valve cusps. The strategy of aortic root replacement combined with mitral repair in these patients produced good results.
Although consensus exists concerning early intervention for severe degenerative MR, 35, 36 the approach to the patient with moderate degenerative MR undergoing aortic root intervention is unclear. 37 The goal of therapy for both severe MR and aortic root aneurysm typically is a prophylactic operation meant to prolong life. Many of these patients are asymptomatic. Not surprisingly, a significant number of them are referred to surgery for one of the primary lesions and are incidentally found to have the other during the preoperative workup. Because we approach most MV disease with a minimally invasive first mindset, patients receive CT imaging of the chest in addition to echocardiography as a routine part of the workup. Likewise, because an understanding of aortic valve function is critical to the decision-making process for aortic root surgery, the patients who present with aortic root disease as the primary indication receive echocardiography in addition to CT. It has been shown that unaddressed MR after aortic valve surgery is associated with increased risks of long-term mortality and heart failure. 38, 39 In the current study, 59 patients (50%) underwent an MV procedure with less than severe MR (>1þ and <4þ), but many of them had signs of advanced findings, including redundant leaflet tissue and a dilated annulus consistent with Barlow's disease. Among this subset of patients, 52 (88%) had MV repair and 7 (12%) had MV replacement; replacements tended to occur earlier in the series and were often in patients with mitral annular calcification. It has been suggested that adding MV surgery to an aortic root/valve procedure increases the risk of mortality by 2-fold, but we did not find that to be the case. 40 There were no operative deaths and no late mitral reoperations in the subset of patients with moderate mitral disease, suggesting that proactive treatment of moderate MR is a safe and reasonable choice in patients undergoing a concomitant root procedure. Only 2 of these patients had more than mild MR 10 years after MV repair. A larger study with longer follow-up will be necessary to determine late clinical benefits associated with a MV procedure for moderate MR in patients undergoing aortic root operation.
In follow-up, 6 patients required MV reoperation and 12 patients required aortic root or valve reoperation. In a recent study by David and colleagues, 2 the freedom from reoperation for combined aortic root and MV procedure was 86% at 10 years, similar to that seen in our cohort; however, their population was different than ours and included patients with endocarditis.
Study Limitations
Inclusion in this study extended over a long period of time during which techniques evolved for treating both the aortic root and MVs, influencing the type of procedure chosen. As a retrospective study, the usual issues inherent to such a strategy limit it. Fourteen patients (14%) were lost to follow-up at different time points before 2-year active follow-up in the whole cohort, and 59% of combined VPRR and MV repair procedures were performed in the last 5 years, resulting in shorter follow-up for this subgroup. Furthermore, we did not have enough follow-up echocardiographic data to report the longitudinal recurrence of MR or AR as completely as that for survival. The study was not designed to compare repair and replacement procedures; however, as we gain more experience with a larger population of patients, we may be able to tease out the advantages of one strategy over another.
Despite the limited numbers of patients with documented connective tissue disorders, this population is relatively young, and it is likely that they have a common and possibly genetically triggered cause for degeneration of both the aorta and the MV. Patients with Marfan syndrome have a higher incidence of MR than the normal population. 4, 41 It is plausible that there may be a unique genetic abnormality in a proportion of these patients who present with both degenerative MR and aortic root dilatation but without other phenotypical features. We have now begun to refer these patients for evaluation with a cardiovascular geneticist and offer them genetic analysis.
CONCLUSIONS
In a high-volume center with dedicated aorta and MV specialists, treatment of combined aortic root pathology and MV disease can be achieved with low operative mortality. Preservation of both valves is often feasible and affords excellent durability. 
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